Two more comments on Mutual Pharmaceutical v Bartlett

I missed these links before when I posted on the Supreme Court's decision in Bartlett so I am posting it now separately.  Pharmalot has a comment here.  Reuters has a report here.

Here is an interesting point in the Reuters report:  Consumer watchdog group Public Citizen said the Supreme Court decision on Monday undermines patient safety at a time when about 80 percent of U.S. prescriptions are filled with generic medicines.  "Today's court decision provides a disincentive for generic makers of drugs to monitor safety of their products and to make sure that they have a surveillance system in place to detect adverse events that pose a threat to patients," Michael Carome, director of Public Citizen's Health Research Group, said in an interview.